Enterprise Solutions Webinars

  1. Manufacture To Control: Considerations In CMC For Antibody-Drug Conjugates 9/18/2024

    The complex nature of ADCs necessitates meticulous attention to CMC. Gain valuable insights for navigating CMC development, ensuring the delivery of safe and efficacious biopharmaceutical products.

  2. Navigating Change: Expert Insights And Best Practices For Ensuring Quality And Consistency In Biologics Comparability Studies 9/16/2024

    Uncover a comprehensive framework for conducting robust comparability studies that ensure biosimilars meet stringent standards for safety, efficacy, and quality.

  3. Mastering Complexity: Strategies For CMC Development And Optimization In The Production Of Multi-Specific Immuno-Cytokines And Fusion Enzymes 9/16/2024

    Discover how implementing a strategic approach to optimize the platform can establish a solid foundation for the efficient, reliable, and successful manufacturing of biopharmaceutical products.

  4. Outsourcing Considerations For Novel Protein Therapeutics 9/13/2024

    Panelists discuss special considerations for outsourcing the development and manufacturing of novel, complex protein therapeutics in this Bioprocess Online Live event.

  5. End-To-End Single-Use Downstream Solution For Bio-Manufacturing 9/4/2024

    Watch to learn about the advantages of applying single-use platform technologies, how to debottleneck process intensification, and much more.

  6. Managing Freeze And Thaw Applications: Single-Use Containers Vs. Bottles 9/4/2024

    Discover the advantages of single-use systems over traditional bottles, including improved quality, flexibility, and safety.

  7. Greatest Challenges In ADC Development & Manufacturing 8/29/2024

    Amy Johnson, Ph.D., VP of Medical Affairs at Vincerx, Sandra Poole, Chief Operating Officer at Mythic Therapeutics, and DeciBio Project Leader Joe Daccache, Ph.D. discuss the greatest challenge to ADC progress and reflect on our audience’s opinions on those challenges, then wrap up with their parting shots.

  8. ADC Scale-Up In A GMP Environment 8/29/2024

    In this segment of the Bioprocess Online Live event, Navigating ADC Manufacturing Complexity, Amy Johnson, Ph.D., VP of Medical Affairs at Vincerx, and Sandra Poole, Chief Operating Officer at Mythic Therapeutics discuss scale-up strategies for ADCs in a GMP environment and entertain audience questions on the topic.

  9. CMC Bottlenecks And Tech Transfer Strategy In ADC Development 8/29/2024

    In this segment of the Bioprocess Online Live event, Navigating ADC Manufacturing Complexity, Amy Johnson, Ph.D., VP of Medical Affairs at Vincerx, Sandra Poole, Chief Operating Officer at Mythic Therapeutics, and DeciBio Project Leader Joe Daccache, Ph.D. discuss early CMC decisions, and how they translate to CDMO/CMO tech transfer.

  10. Orchestrating A Multi-Part ADC Contract Manufacturing Landscape 8/29/2024

    Amy Johnson, Ph.D., VP of Medical Affairs at Vincerx, Sandra Poole, Chief Operating Officer at Mythic Therapeutics, and DeciBio Project Leader Joe Daccache, Ph.D. discuss approaches to managing a highly-fragmented landscape of contract manufacturers in the white-hot antibody-drug conjugate (ADC) space.